Back
New York Times Vs. Janux Therapeutics Industry Stock Comparison
Buy
85
NYT
New York Times
Last Price:
49.04
Seasonality Move:
2.04%
Sell
37
JANX
Janux Therapeutics
Last Price:
47.99
Seasonality Move:
8.69%
Buy
85
New York Times (NYT)
is a Buy
Is New York Times a Buy, Sell or Hold?
- The current New York Times [NYT] share price is $48.81. The Score for NYT is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
- NYT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
37
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
- The current Janux Therapeutics [JANX] share price is $47.10. The Score for JANX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NYT Stock Price Chart
What is New York Times's stock price today?
-
The New York Times share price today is $48.81
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NYT is experiencing slight selling pressure.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $47.10
The current trend is moderately bearish and JANX is experiencing slight selling pressure.
NYT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.43 | Buy |
| Relative Strength Index (14 RSI): | 80.24 | Buy |
| Chaikin Money Flow: | -122323 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.48 - 47.42) | Buy |
| Bollinger Bands (100): | (42.85 - 47.61) | Buy |
JANX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.72 | Buy |
| Relative Strength Index (14 RSI): | 44.16 | Sell |
| Chaikin Money Flow: | -317532 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.78 - 57.84) | Sell |
| Bollinger Bands (100): | (12.31 - 49.41) | Buy |
NYT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.18 | Buy |
| 20-day SMA: | 45.67 | Buy |
| 50-day SMA: | 44.2 | Buy |
| 200-day SMA: | 44.32 | Buy |
| 8-day EMA: | 47.88 | Buy |
| 20-day EMA: | 46.3 | Buy |
| 50-day EMA: | 45.05 | Buy |
| 200-day EMA: | 43.7 | Buy |
JANX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.54 | Sell |
| 20-day SMA: | 52.99 | Sell |
| 50-day SMA: | 45.97 | Buy |
| 200-day SMA: | 20.17 | Buy |
| 8-day EMA: | 49.81 | Sell |
| 20-day EMA: | 50.9 | Sell |
| 50-day EMA: | 45.06 | Buy |
| 200-day EMA: | 26.54 | Buy |
New York Times Earnings Growth & NYT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.09 per share, an increase this year of $0.27 per share, and an increase next year of $0.17 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.05 per share, an increase this year of $0.09 per share, and a decrease next year of $0.57 per share.
New York Times Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Janux Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||